JP2000229832A - Skin lotion - Google Patents
Skin lotionInfo
- Publication number
- JP2000229832A JP2000229832A JP11031325A JP3132599A JP2000229832A JP 2000229832 A JP2000229832 A JP 2000229832A JP 11031325 A JP11031325 A JP 11031325A JP 3132599 A JP3132599 A JP 3132599A JP 2000229832 A JP2000229832 A JP 2000229832A
- Authority
- JP
- Japan
- Prior art keywords
- collagen
- skin
- external preparation
- algae
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000006210 lotion Substances 0.000 title description 4
- 102000008186 Collagen Human genes 0.000 claims abstract description 66
- 108010035532 Collagen Proteins 0.000 claims abstract description 66
- 229920001436 collagen Polymers 0.000 claims abstract description 66
- 238000002360 preparation method Methods 0.000 claims abstract description 52
- 239000000284 extract Substances 0.000 claims abstract description 50
- 239000004480 active ingredient Substances 0.000 claims abstract description 18
- 241000195628 Chlorophyta Species 0.000 claims abstract description 15
- 241000206572 Rhodophyta Species 0.000 claims abstract description 14
- 241000199919 Phaeophyceae Species 0.000 claims abstract description 13
- 241000195649 Chlorella <Chlorellales> Species 0.000 claims abstract description 5
- 241001474374 Blennius Species 0.000 claims description 38
- 239000013535 sea water Substances 0.000 claims description 9
- 230000000694 effects Effects 0.000 abstract description 32
- 229940088594 vitamin Drugs 0.000 abstract description 2
- 239000011782 vitamin Substances 0.000 abstract description 2
- 229930003231 vitamin Natural products 0.000 abstract description 2
- 235000013343 vitamin Nutrition 0.000 abstract description 2
- 241000195493 Cryptophyta Species 0.000 abstract 3
- 241000979956 Cumathamnion serrulatum Species 0.000 abstract 1
- 241000015177 Saccharina japonica Species 0.000 abstract 1
- 239000006096 absorbing agent Substances 0.000 abstract 1
- 239000003906 humectant Substances 0.000 abstract 1
- 150000003722 vitamin derivatives Chemical class 0.000 abstract 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 23
- 206010013786 Dry skin Diseases 0.000 description 18
- 235000019688 fish Nutrition 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- 239000000203 mixture Substances 0.000 description 17
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- 238000009472 formulation Methods 0.000 description 13
- 241000251468 Actinopterygii Species 0.000 description 12
- 239000003921 oil Substances 0.000 description 12
- 239000008213 purified water Substances 0.000 description 12
- 239000003205 fragrance Substances 0.000 description 11
- 235000011187 glycerol Nutrition 0.000 description 11
- 239000008346 aqueous phase Substances 0.000 description 9
- -1 for example Substances 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 8
- 238000013329 compounding Methods 0.000 description 8
- 239000002552 dosage form Substances 0.000 description 8
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 8
- 239000012071 phase Substances 0.000 description 8
- 229940058015 1,3-butylene glycol Drugs 0.000 description 7
- 235000019437 butane-1,3-diol Nutrition 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 238000000605 extraction Methods 0.000 description 7
- 238000002156 mixing Methods 0.000 description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- VBICKXHEKHSIBG-UHFFFAOYSA-N beta-monoglyceryl stearate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 4
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 4
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 4
- 229960002216 methylparaben Drugs 0.000 description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 4
- 229940093430 polyethylene glycol 1500 Drugs 0.000 description 4
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- 235000013871 bee wax Nutrition 0.000 description 3
- 239000012166 beeswax Substances 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 3
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 3
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 3
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 230000003449 preventive effect Effects 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 229940042585 tocopherol acetate Drugs 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 241000972773 Aulopiformes Species 0.000 description 2
- 235000021357 Behenic acid Nutrition 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 101000879758 Homo sapiens Sjoegren syndrome nuclear autoantigen 1 Proteins 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- 241000269908 Platichthys flesus Species 0.000 description 2
- 229920001219 Polysorbate 40 Polymers 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 241001125048 Sardina Species 0.000 description 2
- 102100037330 Sjoegren syndrome nuclear autoantigen 1 Human genes 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 2
- 229940116226 behenic acid Drugs 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 229940082500 cetostearyl alcohol Drugs 0.000 description 2
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Polymers OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 235000008524 evening primrose extract Nutrition 0.000 description 2
- 229940089020 evening primrose oil Drugs 0.000 description 2
- 239000010475 evening primrose oil Substances 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 229960000342 retinol acetate Drugs 0.000 description 2
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 2
- 235000019173 retinyl acetate Nutrition 0.000 description 2
- 239000011770 retinyl acetate Substances 0.000 description 2
- 235000019515 salmon Nutrition 0.000 description 2
- 235000019512 sardine Nutrition 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- QKHBMQWPOUUMQZ-BDQAORGHSA-M sodium;hydron;(2s)-2-(octadecanoylamino)pentanedioate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC([O-])=O QKHBMQWPOUUMQZ-BDQAORGHSA-M 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 2
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 2
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- KNUPSOXBESCJLY-UHFFFAOYSA-N 2-methoxy-1-phenylhexan-1-one Chemical compound CCCCC(OC)C(=O)C1=CC=CC=C1 KNUPSOXBESCJLY-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241000584629 Aosa Species 0.000 description 1
- 241000239290 Araneae Species 0.000 description 1
- 241000512259 Ascophyllum nodosum Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 241000736839 Chara Species 0.000 description 1
- 240000009108 Chlorella vulgaris Species 0.000 description 1
- 235000007089 Chlorella vulgaris Nutrition 0.000 description 1
- 102000009089 Collagen Type XIII Human genes 0.000 description 1
- 108010073180 Collagen Type XIII Proteins 0.000 description 1
- 101150103171 DARS1 gene Proteins 0.000 description 1
- 241000258180 Echinacea <Echinodermata> Species 0.000 description 1
- 241000257465 Echinoidea Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- 241000406668 Loxodonta cyclotis Species 0.000 description 1
- 241000234479 Narcissus Species 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 206010053262 Skin swelling Diseases 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 241000195615 Volvox Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- IWWCATWBROCMCW-UHFFFAOYSA-N batyl alcohol Natural products CCCCCCCCCCCCCCCCCCOC(O)CO IWWCATWBROCMCW-UHFFFAOYSA-N 0.000 description 1
- 229940092738 beeswax Drugs 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 235000014134 echinacea Nutrition 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000003915 liquefied petroleum gas Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- FFZFHRYMHDWKAX-UHFFFAOYSA-N octyl 2-aminobenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1N FFZFHRYMHDWKAX-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229940093932 potassium hydroxide Drugs 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 102220240796 rs553605556 Human genes 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 235000002316 solid fats Nutrition 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、皮膚外用剤に関す
る技術分野の発明である。より具体的には、本発明は、
皮膚のカサツキ等の肌荒れを防止・改善する皮膚外用剤
に関する発明である。TECHNICAL FIELD [0001] The present invention relates to an external preparation for the skin. More specifically, the present invention provides:
The present invention relates to an external preparation for the skin that prevents and improves rough skin such as skin roughness.
【0002】[0002]
【従来の技術】例えば、皮膚のカサツキとして現れる、
肌荒れを防止・改善することは、スキンケアーの基本で
ある。2. Description of the Related Art For example, it appears as skin swelling.
Preventing and improving rough skin is the basis of skin care.
【0003】この肌荒れは、乾燥や紫外線、さらには、
加齢に伴って、皮膚の水分低下、皮膚の厚さの低下等に
より惹き起こされることが知られている。特に、乾燥や
紫外線、さらには、種々の酸化要因による肌のダメージ
は、肌荒れの直接的な原因と考えられている。[0003] This rough skin can be caused by drying, ultraviolet rays,
It is known that the aging is caused by a decrease in skin moisture, a decrease in skin thickness, and the like. In particular, skin damage due to drying, ultraviolet rays, and various oxidizing factors is considered to be a direct cause of rough skin.
【0004】従来においても、このような皮膚の肌荒れ
を防止するために、各種の手段が採られている。例え
ば、乾燥による肌荒れを防止するため、各種の保湿剤を
配合した外用剤、紫外線による肌荒れを防止するために
紫外線吸収剤を配合した外用剤、種々の酸化要因による
肌荒れを防止するためにビタミンE等の抗酸化剤を配合
した外用剤等が用いられてきた。Conventionally, various measures have been taken to prevent such rough skin. For example, an external preparation containing various moisturizers to prevent skin roughness due to drying, an external preparation containing an ultraviolet absorber to prevent skin roughness due to ultraviolet rays, and vitamin E to prevent skin roughness due to various oxidation factors. External preparations and the like containing an antioxidant such as the above have been used.
【0005】しかしながら、これらの従来の肌荒れ防止
手段は、対処療法的な意味合いが強く、肌荒れに対して
十分な対処がなされているとは、言い得ない状況であ
る。[0005] However, these conventional means for preventing skin roughness have a significant therapeutic effect, and it cannot be said that sufficient measures have been taken against skin roughness.
【0006】[0006]
【発明が解決しようとする課題】本発明が解決すべき課
題は、肌荒れに対して抑制的に働く要素を新たに見出し
て、この要素を用いることにより、効果的に肌荒れを予
防・改善する手段を提供することにある。The problem to be solved by the present invention is to find a new element which works to suppress skin roughness and to use this element to effectively prevent and improve rough skin. Is to provide.
【0007】[0007]
【課題を解決するための手段】本発明者は、肌荒れに対
して抑制的に働く要素を見出すべく、鋭意検討を行っ
た。その結果、コラーゲン、特に海洋性コラーゲンと海
藻抽出物を組み合わせて、皮膚外用剤の有効成分として
用いることにより、肌荒れに対する優れた予防・改善効
果が得られることを見出し、本発明を完成した。Means for Solving the Problems The inventor of the present invention has conducted intensive studies in order to find an element that acts to suppress skin roughness. As a result, they have found that excellent preventive and ameliorating effects on skin roughness can be obtained by using collagen, particularly marine collagen, and a seaweed extract as an active ingredient in an external preparation for skin, and completed the present invention.
【0008】すなわち、本発明は、コラーゲン、特に海
洋性コラーゲン及び海藻抽出物を有効成分とする皮膚外
用剤を提供する発明である(以下、本発明皮膚外用剤と
いう)。That is, the present invention is an invention for providing an external preparation for skin containing collagen, particularly marine collagen and seaweed extract as an active ingredient (hereinafter referred to as the external preparation for skin of the present invention).
【0009】なお、本発明において、「海洋性コラーゲ
ン」とは、動物ではなく、魚類に由来するコラーゲンの
ことを意味する。かかる海洋性コラーゲンの詳細につい
ては、後述する。[0009] In the present invention, "marine collagen" means collagen derived not from animals but from fish. Details of such marine collagen will be described later.
【0010】また、本発明皮膚外用剤に、さらに海水乾
燥物を配合することにより、保湿効果を、本発明皮膚外
用剤に付与することが可能であり、本発明は、このよう
な態様の皮膚外用剤をも提供する。[0010] Further, it is possible to impart a moisturizing effect to the external preparation for skin of the present invention by further mixing a dried seawater with the external preparation for skin of the present invention. An external preparation is also provided.
【0011】[0011]
【発明の実施の形態】以下、本発明の実施の形態につい
て説明する。 A.本発明皮膚外用剤の有効成分について:本発明皮膚
外用剤の有効成分は、上述のように、コラーゲン及び海
藻抽出物である。Embodiments of the present invention will be described below. A. Regarding the active ingredient of the external preparation for skin of the present invention : As described above, the active ingredients of the external preparation for skin of the present invention are collagen and seaweed extract.
【0012】本発明皮膚外用剤の有効成分として用いら
れるコラーゲンは、特に限定されず、I 型からXIII型の
コラーゲンのいずれをも用いることができる。現実的に
は、コラーゲンは、各種の動物や魚類から得られるコラ
ーゲンを用いることが想定されるが、このコラーゲンの
出所となる動物(例えば、牛、豚等)や魚類(例えば、
ヒラメ、サケ、イワシ、マグロ等)の種類や、コラーゲ
ンの抽出部位も、骨、皮、腱、ウキブクロ(魚類)等が
可能である。The collagen used as an active ingredient of the external preparation for skin of the present invention is not particularly limited, and any type I to type XIII collagen can be used. In reality, it is assumed that collagen obtained from various animals and fishes is used as the collagen. However, animals (eg, cows, pigs, etc.) and fishes (eg,
Flounder, salmon, sardine, tuna, etc.) and collagen extraction sites can be bones, skins, tendons, duckfishes (fishes) and the like.
【0013】そして、本発明においては、特に、前述の
ごとく、魚類に由来する海洋性コラーゲンを好ましいコ
ラーゲンとして用いることができる。海洋性コラーゲン
は、動物性コラーゲンに比べ、角質柔軟効果に優れ、さ
らに安全性においても優れている。[0013] In the present invention, as described above, marine collagen derived from fish can be used as a preferred collagen. Marine collagen is superior in animal skin collagen in keratin softening effect and safety.
【0014】これらの成分からのコラーゲンの抽出・精
製は、通常公知の方法を用いて行うことができる。具体
的には、例えば、骨、皮、腱、ウキブクロ等のコラーゲ
ンを含有する組織を粉砕した後、水洗、希塩溶液による
抽出、酸若しくはアルカリ溶液による抽出、ペプシン,
トリプシンやヒアルロニダーゼ等の酵素による抽出し
て、塩析や透析等の公知の精製手段を施して、コラーゲ
ンを精製して得ることができる。また、通常公知の方法
により、「再生コラーゲン」として得ることも可能であ
る。The extraction and purification of collagen from these components can be carried out by a generally known method. Specifically, for example, after crushing a tissue containing collagen such as bone, skin, tendon, and sea urchin, washing with water, extraction with a dilute salt solution, extraction with an acid or alkali solution, pepsin,
The collagen can be obtained by extraction with an enzyme such as trypsin or hyaluronidase and subjecting it to a known purification means such as salting out or dialysis to purify collagen. It is also possible to obtain “regenerated collagen” by a generally known method.
【0015】また、市販のコラーゲン〔例えば、商品
名:コラーゲンMO(瑞穂商事株式会社)、商品名:PA
NCOGEN MARIN(池田物産株式会社)等〕を本発明皮膚外
用剤の有効成分として用いることも可能である。A commercially available collagen [for example, trade name: Collagen MO (Mizuho Trading Co., Ltd.), trade name: PA]
NCOGEN MARIN (Ikeda Bussan Co., Ltd.) etc.] can also be used as an active ingredient of the skin external preparation of the present invention.
【0016】本発明皮膚外用剤における、コラーゲンの
配合量は、他の有効成分である、海藻抽出物の配合量や
本発明皮膚外用剤の具体的な剤形等により、適宜選択す
ることが可能であり、特に限定されるものではないが、
一般に、剤全体に対して0.000001〜0.1重量
%(有効分)が好ましく、有効性と使用性等を考慮する
と同0.00001〜0.01重量%(有効分)が特に
好ましい。この配合量が、剤全体に対して0.0000
01重量%(有効分)未満であると、肌荒れに対する十
分な予防・改善効果を発揮し難くなり好ましくなく、逆
に同0.1重量%(有効分)を超えて配合しても、配合
量の増加に見合った肌荒れ予防・改善効果の増強が認め
られ難くなるばかりか、べたついた使用感等を伴う傾向
が強くなり、好ましくない。The amount of collagen in the external preparation for skin of the present invention can be appropriately selected depending on the amount of other active ingredients, ie, the amount of seaweed extract and the specific dosage form of the external preparation for skin of the present invention. Is not particularly limited,
Generally, the amount is preferably 0.000001 to 0.1% by weight (active component) with respect to the whole agent, and particularly preferably 0.00001 to 0.01% by weight (active component) in consideration of effectiveness and usability. This compounding amount is 0.0000
When the amount is less than 01% by weight (effective amount), it is difficult to exert a sufficient preventive and ameliorating effect on the rough skin, which is not preferable. In addition to the increase in the effect of preventing and improving rough skin corresponding to the increase in the skin roughness, it is difficult to recognize the effect, and the tendency to accompany the sticky feeling becomes strong.
【0017】本発明皮膚外用剤の有効成分として用いら
れる海藻抽出物は、特に限定されないが、通常、本発明
においては、緑藻類、紅藻類及び/又は褐藻類に属する
海藻類から抽出された海藻抽出物が用いられる。The seaweed extract used as an active ingredient of the external preparation for skin of the present invention is not particularly limited, but usually, in the present invention, seaweed extract extracted from seaweeds belonging to green algae, red algae and / or brown algae Object is used.
【0018】緑藻類に属する海藻としては、例えば、シ
ャジクモ類、ホシミドロ類、ミル類、ハネモ類、カサノ
リ類、ミドリゲ類、シオグサ類、アオサ類、ヒビミドロ
類、カワノリ類、クロレラ類、クンショウモ類、ボルボ
クス類等に属する海藻が挙げられ、紅藻類に属する海藻
としては、例えば、イギス類、マサゴシバリ類、スギノ
リ類、カクレイト類、ダルス類、テングサ類、カギノリ
類、ウミゾウメン類、オオイシソウ類、ウシケノリ類、
チノリモ類等に属する海藻が挙げられ、褐藻類に属する
海藻としては、例えば、ホンダワラ類、コンブ類等に属
する海藻が挙げられる。Examples of the seaweeds belonging to the green algae include Chara spiders, Echinacea spp., Mills, Janemo, Casanori, Midorige, Shiogusa, Aosa, Hibimidoro, Kawanori, Chlorella, Kungsho, Volvox Examples of seaweeds belonging to red algae include, for example, guinea pigs, masagoshibari, ginatoi, caclates, dars, tengusa, kaginori, sea elephant, narcissus, oxenori,
Seaweeds belonging to chinorimos and the like are mentioned, and seaweeds belonging to brown algae include seaweeds belonging to Honda straw, kelp and the like.
【0019】本発明においては、緑藻類としては、クロ
レラ類に属するクロレラがコラーゲン合成促進効果に優
れ好ましく、紅藻類としては、イギス類に属するヌメハ
ノリが保湿効果に優れ好ましく、褐藻類としては、コン
ブ類に属するマコンブに、スリミング効果が認められ、
好ましい。In the present invention, Chlorella belonging to Chlorella is preferable as a green algae because of its excellent effect of promoting collagen synthesis, Numehanori belonging to Igis is preferable as a red algae and a moisturizing effect is preferable. Slimming effect is recognized in Macomb belonging to
preferable.
【0020】本発明皮膚外用剤においては、これらの海
藻の1種又は2種以上を選んで、これらの海藻抽出物を
配合することにより、本発明の所期の効果である肌荒れ
予防・改善効果を発揮することができる。In the external preparation for skin of the present invention, one or more of these seaweeds are selected and blended with these seaweed extracts to prevent or improve the rough skin, which is the desired effect of the present invention. Can be demonstrated.
【0021】これらの海藻抽出物は、選択された海藻か
ら、通常公知の抽出方法を用いて抽出され得る。すなわ
ち、例えば、水、親水性有機溶剤(アルコール等)、水
と親水性有機溶剤の混合液、多価アルコール(グリセリ
ン、1, 3−ブチレングリコール等)、水と多価アルコ
ールとの混合液により抽出され得る。These seaweed extracts can be extracted from the selected seaweed using a generally known extraction method. That is, for example, water, a hydrophilic organic solvent (alcohol or the like), a mixed solution of water and a hydrophilic organic solvent, a polyhydric alcohol (glycerin, 1,3-butylene glycol or the like), or a mixed solution of water and a polyhydric alcohol Can be extracted.
【0022】また、各種の市販の海藻抽出物〔例えば、
商品名:Dermochlorelle D(日光ケミカルズ株式会
社)、商品名:Rh.Deless HG(日光ケミカルズ株式会
社)、商品名:PHYCOL LD BG(グンゼ産業株式会社)
等〕を本発明皮膚外用剤の有効成分として用いることも
可能である。Also, various commercially available seaweed extracts [for example,
Product name: Dermochlorelle D (Nikko Chemicals Co., Ltd.), Product name: Rh.Deless HG (Nikko Chemicals Co., Ltd.), Product name: PHYCOL LD BG (Gunze Sangyo Co., Ltd.)
Etc.] can also be used as an active ingredient of the external preparation for skin of the present invention.
【0023】本発明皮膚外用剤における、海藻抽出物の
配合量は、他の有効成分である、具体的に選択した海藻
抽出物の種類、他の有効成分であるコラーゲンの配合量
や本発明皮膚外用剤の具体的な剤形等により、適宜選択
することが可能であり、特に限定されるものではない
が、一般に、剤全体に対して0.000001〜0.2
重量%(有効分)が好ましく、同0.00001〜0.
1重量%(有効分)が特に好ましい。この配合量が、剤
全体に対して0.000001重量%(有効分)未満で
あると、肌荒れに対する十分な予防・改善効果を発揮し
難くなり好ましくなく、逆に同0.2重量%(有効分)
を超えて配合しても、配合量の増加に見合った肌荒れ予
防・改善効果の増強が認められ難くなるばかりか、べた
ついた使用感等を伴う傾向が強くなり、好ましくない。The amount of the seaweed extract in the external preparation for skin of the present invention depends on the type of the seaweed extract specifically selected as the other active ingredient, the amount of the collagen as the other active ingredient, and the amount of the skin of the present invention. Depending on the specific dosage form of the external preparation and the like, it can be appropriately selected and is not particularly limited, but is generally 0.000001 to 0.2 with respect to the whole preparation.
% By weight (effective component), preferably from 0.00001 to 0.1%.
1% by weight (active) is particularly preferred. If this compounding amount is less than 0.000001% by weight (active component) with respect to the whole agent, it is difficult to exert a sufficient preventive / improving effect on skin roughness, which is not preferable. Minutes)
When the amount exceeds the above range, it is difficult to enhance the effect of preventing and improving rough skin in proportion to the increase in the amount of the compounded compound, and it is also not preferable because it tends to have a sticky feeling of use.
【0024】このように、有効成分として、コラーゲン
及び海藻抽出物を組み合わせて用いることにより、優れ
た肌荒れ予防・改善効果を、本発明皮膚外用剤において
発揮させることができる。As described above, by using collagen and seaweed extract in combination as active ingredients, excellent skin roughness prevention / improvement effects can be exerted in the skin external preparation of the present invention.
【0025】本発明皮膚外用剤には、上述の海洋性コラ
ーゲン等のコラーゲンと海藻抽出物に加えて、海水乾燥
物を配合することで、使用者の肌に、海水ミネラルを補
給することにより、保湿性を向上させることができる。The external preparation for skin of the present invention comprises a seawater mineral added to the skin of a user by blending a seawater dried product in addition to the above-mentioned collagen such as marine collagen and a seaweed extract. Moisture retention can be improved.
【0026】本発明皮膚外用剤において、この海水乾燥
物を配合する場合には、その配合量は、剤全体に対して
0.001〜10.0重量%程度であることが一般的に
は好ましい。この配合量が剤全体に対して0.001重
量%未満であると、一般に肌に供給される海水ミネラル
量が十分ではなく、海水ミネラルの補給による効果を、
十分に発揮させることが困難であり好ましくない。ま
た、逆に、この配合量が剤全体に対して10.0重量%
を超えて配合すると、一般に、剤の安定性が損なわれる
傾向が強くなり、好ましくない。 B.本発明皮膚外用剤の具体的な態様について:本発明
皮膚外用剤には、上述の有効成分以外に、必要に応じ
て、本発明の所期の効果を損なわない範囲において、皮
膚外用剤一般に用いられる各種の成分を配合することが
できる。When this seawater dried product is blended in the skin external preparation of the present invention, it is generally preferred that the blending amount is about 0.001 to 10.0% by weight based on the whole preparation. . If this amount is less than 0.001% by weight based on the whole agent, the amount of seawater mineral generally supplied to the skin is not sufficient, and the effect of replenishing seawater minerals is
It is difficult to fully exert the effect, which is not preferable. Conversely, this compounding amount is 10.0% by weight based on the whole agent.
When the amount exceeds the above range, the stability of the agent tends to be generally impaired, which is not preferable. B. Specific embodiments of the external preparation for skin of the present invention : In addition to the above-mentioned active ingredients, the external preparation for skin of the present invention is generally used as needed, as long as the intended effect of the present invention is not impaired. Various components can be blended.
【0027】また、本発明皮膚外用剤の剤形は任意であ
り、例えば油状製剤、化粧水系の可溶化系の剤形;乳
液、クリーム等の乳化系の剤形;軟膏、分散液、粉末等
の剤形を、特別な制限なしに採ることができる。The dosage form of the external preparation for skin of the present invention is arbitrary, for example, an oily preparation, a solubilizing dosage form of a lotion; an emulsifying dosage form such as an emulsion or a cream; an ointment, a dispersion, a powder, etc. Dosage form can be taken without particular restrictions.
【0028】本発明皮膚外用剤においては、主に特定の
薬効的な作用を付加するために、例えば、ビタミン類、
保湿剤、紫外線吸収剤、消炎剤、美白剤、本発明皮膚外
用剤の有効成分を除外した動植物抽出物、賦活剤、血行
促進剤、抗脂漏剤等を配合することができる。In the skin external preparation of the present invention, in order to mainly add a specific pharmacological effect, for example, vitamins,
A moisturizer, an ultraviolet absorber, an anti-inflammatory agent, a whitening agent, an animal or plant extract excluding the active ingredient of the external preparation for skin of the present invention, an activator, a blood circulation promoter, an antiseborrheic agent, and the like can be added.
【0029】また、本発明皮膚外用剤を、主に所望する
剤形とするために、例えば、液体油脂、固体油脂、ロウ
類、炭化水素油等の油分;高級脂肪酸、高級アルコー
ル、合成エステル油、シリコーン、各種の界面活性剤、
防腐剤、各種の水溶性高分子、各種粉末成分、顔料、色
素、香料、水等を、必要に応じて配合することができ
る。In order to prepare the skin external preparation of the present invention into a desired dosage form, for example, oils such as liquid fats and oils, solid fats and oils, waxes, hydrocarbon oils; higher fatty acids, higher alcohols and synthetic ester oils , Silicone, various surfactants,
Preservatives, various water-soluble polymers, various powder components, pigments, dyes, fragrances, water, and the like can be added as necessary.
【0030】特に、香料として、ハーブ香料を調合し
て、リラックス感を感じさせる香りを本発明皮膚外用剤
に付与することにより、本発明皮膚外用剤にリラックス
効果を付与したり、海の香りを再現した香料を用いて、
本発明皮膚外用剤の使用者に、あたかも海辺にいるよう
な仮想体験をさせて、心身の一層のリフレッシュを図る
ことが可能である。In particular, a herb fragrance is prepared as a fragrance to impart a relaxing scent to the external preparation of the present invention, thereby imparting a relaxing effect to the external preparation of the present invention or imparting a scent of the sea. Using the reproduced fragrance,
The user of the external preparation for skin of the present invention can have a virtual experience as if he were at the seaside, thereby further refreshing the mind and body.
【0031】本発明皮膚外用剤の具体的な剤形は、後述
する実施例において記載する。The specific dosage form of the skin external preparation of the present invention will be described in Examples described later.
【0032】[0032]
【実施例】本発明を実施例を用いてさらに具体的に説明
するが、本発明の技術的範囲はそれにより限定されるべ
きものではない。なお、特に断わらない限り、本実施例
中においては、配合量は、配合される対象に対する重量
%で表示する。EXAMPLES The present invention will be described more specifically with reference to examples, but the technical scope of the present invention should not be limited thereby. In addition, unless otherwise specified, in this example, the compounding amount is represented by% by weight based on the compounded object.
【0033】本発明における有効成分 コラーゲン:本実施例(試験例及び処方例)におい
て、コラーゲンは、商品名PANCOGEN MARIN(池田物産株
式会社:選別したヒラメ,サケ,イワシ及びマグロの皮
ないし骨髄組織から抽出・精製されたコラーゲン、以
下、魚由来コラーゲンともいう)又は商品名コラーゲン
MO(瑞穂商事株式会社:牛又は豚の皮膚組織から得た
エーテル可溶物、以下、動物性コラーゲンともいう)を
用いた。 Active ingredient collagen in the present invention : In the present examples (test examples and prescription examples), collagen was obtained from PANCOGEN MARIN (trade name of Ikeda Bussan Co., Ltd .: selected from flounder, salmon, sardine and tuna skin or bone marrow tissue). Extracted / purified collagen (hereinafter also referred to as fish-derived collagen) or collagen MO (trade name: Mizuho Shoji Co., Ltd .: ether soluble matter obtained from bovine or porcine skin tissue; hereinafter also referred to as animal collagen) Was.
【0034】海藻抽出物:本実施例において、海藻抽
出物は、商品名Dermochlorella D〔日光ケミカルズ株
式会社:緑藻類(Chlorella vulgaris Chick) の低温水
出物、以下、緑藻抽出物ともいう〕、商品名Rh.Deless
HG(日光ケミカルズ株式会社:紅藻類の抽出物、以
下、紅藻抽出物ともいう)、商品名PHYCOL LD BG(グン
ゼ産業株式会社:褐藻類の抽出物、以下、褐藻類抽出物
ともいう)を用いた。Seaweed extract: In this example, the seaweed extract is trade name Dermochlorella D [Nikko Chemicals Co., Ltd .: low-temperature water extract of green algae (Chlorella vulgaris Chick), hereinafter also referred to as green algae extract]. Rh.Deless
HG (Nikko Chemicals Co., Ltd .: Red algae extract, hereinafter also referred to as Red algae extract), trade name PHYCOL LD BG (Gunze Sangyo Co., Ltd .: Brown algae extract, hereinafter also referred to as Brown algae extract) Using.
【0035】試験例(肌荒れ改善効果についての試験) <試験方法>ヒトの上腕に、0.1%ラウリル硫酸ナト
リウム水溶液を、3日間連続して塗布し、人工的に肌荒
れ状態をつくった。その後、第1表及び第2表に示すよ
うに、コラーゲン、海藻抽出物の混合水溶液を1日毎
に、3週間連続して、前記上碗に塗布し、その部分の肌
荒れ状態を、目視により観察し、肌荒れ改善効果の度合
いを点数化し評価した(それぞれn=5名)。 Test Example (Test for Roughness Improvement Effect) <Test Method> A 0.1% aqueous solution of sodium lauryl sulfate was applied continuously to the upper arm of a human for three days to artificially create a roughened skin. Thereafter, as shown in Tables 1 and 2, a mixed aqueous solution of collagen and seaweed extract was applied to the upper bowl every day for three weeks continuously, and the rough skin condition of the portion was visually observed. Then, the degree of skin roughness improvement effect was scored and evaluated (n = 5 each).
【0036】<判断スコア> 顕著な改善効果が認められた: 4 改善効果が認められた:3 若干改善効果が認められた:2 あまり改善効果が認められなかった:1 改善効果が認められなかった:0 <試験結果>この試験の結果を、第1表〜第3表に示
す。なお、各表中のコラーゲン及び海藻抽出物の配合量
の表示は、全て有効分で表した。<Judgment Score> A remarkable improvement effect was recognized: 4 An improvement effect was recognized: 3 A slight improvement effect was recognized: 2 A little improvement effect was not recognized: 1 An improvement effect was not recognized <0 Test Results> The results of this test are shown in Tables 1 to 3. In addition, the indication of the compounding amount of the collagen and the seaweed extract in each table was all expressed by effective components.
【0037】[0037]
【表1】 第 1 表 ─────────────────────────────────── 魚由来コラーゲン 紅藻抽出物 改善効果(平均) ─────────────────────────────────── 1 0.15% 0.05% 3.7 2 0.1 % 0.05% 3.8 3 0.01% 0.05% 3.8 4 0.005 % 0.05% 3.7 試験例 5 0.001 % 0.05% 3.6 6 0.0001% 0.05% 3.5 7 0.00001 % 0.05% 3.5 8 0.000001% 0.05% 2.8 9 0.0000001 % 0.05% 2.0 比較例 1 0 % 0.05% 1.3 ─────────────────────────────────── 第1表から、コラーゲンは、0.00001〜0.01
重量%(有効分)配合することが、特に好適であり、コ
ラーゲンの配合量が0.000001重量%(有効分)
未満では、肌荒れ予防・改善効果が弱くなることが明ら
かになった。[Table 1] Table 1 コ ラ ー ゲ ン Improvement of fish-derived collagen red algae extract Effect (average) ─────────────────────────────────── 1 0.15% 0.05% 3.7 2 0.1% 0.05% 3.8 3 0.01% 0.05% 3.8 4 0.005% 0.05% 3.7 Test Example 5 0.001% 0.05% 3.6 6 0.0001% 0.05% 3.5 7 0.00001% 0.05% 3.5 8 0.000001% 0.05% 2.8 9 0.0000001% 0.05% 2.0 Comparative Example 10% 0.05% 1.3%か ら From Table 1, collagen is 0.00001-0.01
% By weight (effective component) is particularly preferable, and the amount of collagen is 0.000001% by weight (active component).
It was found that the effect of preventing and improving skin roughness was weak when the amount was less than the above.
【0038】また、コラーゲンの配合量が0.1重量%
以上(試験例1,2)では、試験品がべたつく傾向が認
められた。The amount of collagen is 0.1% by weight.
In the above (Test Examples 1 and 2), the test article tended to be sticky.
【0039】[0039]
【表2】 第 2 表 ─────────────────────────────────── 魚由来コラーゲン 緑藻抽出物 改善効果(平均) ─────────────────────────────────── 10 0.001 % 0.3 % 3.6 11 0.001 % 0.2 % 3.7 12 0.001 % 0.1 % 3.6 13 0.001 % 0.05% 3.2 14 0.001 % 0.01% 3.0 試験例 15 0.001 % 0.001 % 2.8 16 0.001 % 0.0001% 2.7 17 0.001 % 0.00001 % 2.6 18 0.001 % 0.000001% 2.0 19 0.001 % 0.0000001 % 1.5 比較例 2 0.001 % 0 % 1.2 比較例 3 0 % 0 % 1.0 ─────────────────────────────────── 第2表により、海藻抽出物の配合量は、0.00000
1〜0.2重量%(有効分)が好ましく、0.0000
01重量%(有効分)未満であると、コラーゲンとの組
み合わせ配合による肌荒れ予防・改善効果が弱くなるこ
とが困難であることが明らかになった。[Table 2] Table II ─────────────────────────────────── Fish-derived collagen Green algae extract Improvement effect (Average) 10 10 0.001% 0.3% 3.6 11 0.001% 0.2 % 3.7 12 0.001% 0.1% 3.6 13 0.001% 0.05% 3.2 14 0.001% 0.01% 3.0 Test example 15 0.001% 0.001% 2.8 16 0.001% 0.0001% 2.7 170.001% 0.00001 % 2.6 18 0.001% 0.000001% 2.0 19 0.001% 0.0000001% 1.5 Comparative example 2 0.001% 0% 1.2 Comparative example 30% 0% 1.0に よ り According to Table 2, the amount of seaweed extract was 0.00000
1 to 0.2% by weight (effective component) is preferable, and
When the amount is less than 01% by weight (effective amount), it has been found that it is difficult to weaken the effect of preventing and improving rough skin by combination with collagen.
【0040】また、コラーゲンの配合量が0.2重量%
以上(試験例10,11)では、試験品がべたつく傾向
が認められた。The amount of collagen was 0.2% by weight.
In the above (Test Examples 10 and 11), the test article had a tendency to be sticky.
【0041】[0041]
【表3】 第 3 表 ─────────────────────────────────── 魚由来コラーゲン 緑藻抽出物 褐藻抽出物 改善効果(平均) ─────────────────────────────────── 試験例 20 0.1 % 0.1 % 0 % 2.8 21 0.1 % 0.1 % 0.1 % 3.9 比較例 4 0.1 % 0 % 0 % 1.3 比較例 5 0 % 0.1 % 0 % 1.0 比較例 6 0 % 0 % 0.1 % 1.2 ─────────────────────────────────── 第3表により、コラーゲンと、2種の海藻抽出物を組み
合わせて用いることにより、肌荒れ予防・防止効果を得
ることが可能であることが明らかになった。[Table 3] Table III-Fish-derived collagen Green algae extract Brown algae extract Product improvement effect (average) ─────────────────────────────────── Test example 20 0.1% 0.1% 0% 2.8 21 0.1% 0.1% 0.1% 3.9 Comparative example 4 0.1% 0% 0% 1.3 Comparative example 50% 0.1% 0% 1.0 Comparative example 60% 0% 0.1% 1.2%に よ り According to Table 3, the combination of collagen and two kinds of seaweed extract It has been clarified that it is possible to obtain the effect of preventing / preventing rough skin by using such a material.
【0042】なお、上記の試験において、肌荒れ改善効
果が認められることは、当然、新たな肌荒れが発生する
ことを予防する、肌荒れ予防効果も認められることを意
味するものである。It should be noted that, in the above test, the effect of improving skin roughness is recognized, of course, that the effect of preventing skin roughness, which prevents the occurrence of new skin roughness, is also recognized.
【0043】以下、本発明皮膚外用剤の具体的な処方
を、処方例として例示列挙する。なお、これらの処方例
の本発明皮膚外用剤に、上述の肌荒れ改善効果について
の試験を行ったところ、いずれの処方例についても、優
れた効果が認められた。なお、これらの処方例における
コラーゲン及び海藻抽出物の配合量の表示は、全て有効
分で表した。Hereinafter, specific formulations of the skin external preparation of the present invention will be exemplified as formulation examples. In addition, when the test for the above-mentioned skin roughness improvement effect was performed on the skin external preparations of the present invention in these formulation examples, excellent effects were recognized in all the formulation examples. In addition, the indication of the compounding amount of the collagen and the seaweed extract in these formulation examples was all expressed by effective components.
【0044】 〔処方例1〕 化粧水 配合成分 配合量(重量%) (1)魚由来コラーゲン 0.005 (2)褐藻抽出物 0.02 (3)酢酸トコフェロール 0.01 (4)グリセリン 4.0 (5)1, 3−ブチレングリコール 4.0 (6)エタノール 8.0 (7)ポリオキシエチレン(60)硬化ヒマシ油 0.5 (8)メチルパラベン 0.2 (9)クエン酸 0.05 (10)クエン酸ソーダ 0.1 (11)香料 0.05 (11)精製水 残 量 〈製法〉精製水に、魚由来コラーゲン、褐藻抽出物、ク
エン酸、クエン酸ソーダ、グリセリン、1, 3−ブチレ
ングリコールを溶解した。これとは別に、エタノールに
ポリオキシエチレン(60)硬化ヒマシ油、酢酸トコフ
ェロール、香料、メチルパラベンを溶解し、これを前記
の水相に加えて可溶化し、濾過して化粧水を得た。[0044] Formulation Example 1 Lotion Ingredients Amount (wt%) (1) from fish collagen 0.005 (2) brown algae extract 0.02 (3) Tocopherol acetate 0.01 (4) Glycerol 4. 0 (5) 1,3-butylene glycol 4.0 (6) Ethanol 8.0 (7) Polyoxyethylene (60) hydrogenated castor oil 0.5 (8) Methyl paraben 0.2 (9) Citric acid 0.05 (10) Sodium citrate 0.1 (11) Fragrance 0.05 (11) Residual purified water <Production method> In purified water, fish-derived collagen, brown algae extract, citric acid, sodium citrate, glycerin, 1,3 -Butylene glycol was dissolved. Separately, polyoxyethylene (60) hydrogenated castor oil, tocopherol acetate, perfume, and methyl paraben were dissolved in ethanol, added to the above aqueous phase, solubilized, and filtered to obtain a lotion.
【0045】 〔処方例2〕 クリーム 配合成分 配合量(重量%) (1)セトステアリルアルコール 3.5 (2)スクワラン 40.0 (3)ミツロウ 3.0 (4)還元ラノリン 5.0 (5)エチルパラベン 0.3 (6)ポリオキシエチレン(20)ソルビタン モノパルミチン酸エステル 2.0 (7)ステアリン酸モノグリセリド 2.0 (8)N−ステアロイルグルタミン酸ナトリウム 0.5 (9)メトキシケイ皮酸オクチル 1.0 (10)酢酸レチノール 2.0 (11)月見草油 0.05 (12)香料 0.03 (13)魚由来コラーゲン 0.1 (14)緑藻抽出物 0.05 (15)ポリエチレングリコール1500 5.0 (16)精製水 残 量 〈製法〉セトステアリルアルコール、スクワラン、ミツ
ロウ、還元ラノリン、エチルパラベン、ポリオキシエチ
レン(20)ソルビタンモノパルミチン酸エステル、ス
テアリン酸モノグリセリド、N−ステアロイルグルタミ
ン酸ナトリウム、メトキシケイ皮酸オクチル、酢酸レチ
ノール、月見草油、香料を加熱溶解した(油相)。これ
とは別に、精製水に、魚由来コラーゲン、緑藻抽出物、
ポリエチレングリコール1500を溶解し、70℃に保
った(水相)。この水相に、前記の油相を撹拌しながら
添加した。次いで、これにホモミキサー処理を施し、乳
化粒子を細かくした後、撹拌しながら急冷し、クリーム
を得た。[Formulation Example 2] Cream blending component blending amount (% by weight) (1) cetostearyl alcohol 3.5 (2) squalane 40.0 (3) beeswax 3.0 (4) reduced lanolin 5.0 (5 ) Ethyl paraben 0.3 (6) polyoxyethylene (20) sorbitan monopalmitate 2.0 (7) monoglyceride stearate 2.0 (8) sodium N-stearoyl glutamate 0.5 (9) methoxycinnamic acid Octyl 1.0 (10) Retinol acetate 2.0 (11) Evening primrose oil 0.05 (12) Fragrance 0.03 (13) Fish-derived collagen 0.1 (14) Green algae extract 0.05 (15) Polyethylene glycol 1500 5.0 (16) Residual amount of purified water <Production method> cetostearyl alcohol, squalane, beeswax, reduced lanolin, Ethyl paraben, polyoxyethylene (20) sorbitan monopalmitate, stearic acid monoglyceride, sodium N-stearoylglutamate, octyl methoxycinnamate, retinol acetate, evening primrose oil, and a fragrance were heated and dissolved (oil phase). Separately, purified water, fish-derived collagen, green algae extract,
Polyethylene glycol 1500 was dissolved and kept at 70 ° C. (aqueous phase). The oil phase was added to the aqueous phase with stirring. Next, this was subjected to a homomixer treatment to make the emulsified particles fine, and then rapidly cooled with stirring to obtain a cream.
【0046】 〔処方例3〕 乳液配合成分 配合量(重量%) (1)パラジメチルアミノ安息香酸−2−エチルヘキシル 0.1 (2)ジパラメトキシケイ皮酸モノー2ーエチルヘキシル 0.2 (3)ステアリン酸 1.5 (4)セチルアルコール 0.5 (5)ミツロウ 2.0 (6)ポリオキシエチレン(10)モノオレイン酸エステル 2.0 (7)L−アルギニン 0.3 (8)海水乾燥物 0.02 (9)PCA−Na 0.05 (10)魚由来コラーゲン 0.002 (11)紅藻抽出物 0.00001 (12)グリセリン 3.0 (13)エタノール 3.0 (14)エチルパラベン 0.3 (15)香料 0.03 (16)カルボキシビニルポリマー 0.12 (17)精製水 残 量 〈製法〉精製水に、魚由来コラーゲン、紅藻抽出物、L
−アルギニン、海水乾燥物、PCA−Na、グリセリ
ン、エタノール、カルボキシビニルポリマーを加えて加
熱溶解し、70℃に保った(水相)。他の成分を混合
し、加熱溶解して、70℃に保った(油相)。前記水相
に、この油相を加えて予備乳化を行い、ホモミキサーで
均一に乳化した。その後、撹拌しながら急冷して乳液を
得た。Formulation Example 3 Emulsion Formulation Component Content (% by Weight) (1) 2-ethylhexyl paradimethylaminobenzoate 0.1 (2) Mono-2-ethylhexyl diparamethoxycinnamate 0.2 (3 ) Stearic acid 1.5 (4) Cetyl alcohol 0.5 (5) Beeswax 2.0 (6) Polyoxyethylene (10) monooleate 2.0 (7) L-arginine 0.3 (8) Seawater Dried product 0.02 (9) PCA-Na 0.05 (10) Fish-derived collagen 0.002 (11) Red algae extract 0.00001 (12) Glycerin 3.0 (13) Ethanol 3.0 (14) Ethylparaben 0.3 (15) Fragrance 0.03 (16) Carboxyvinyl polymer 0.12 (17) Residual purified water <Process> Extraction of fish-derived collagen and red algae into purified water , L
-Arginine, dried seawater, PCA-Na, glycerin, ethanol, carboxyvinyl polymer were added and dissolved by heating, and kept at 70 ° C (aqueous phase). The other components were mixed, dissolved by heating, and kept at 70 ° C. (oil phase). This oil phase was added to the aqueous phase to perform preliminary emulsification, and the mixture was uniformly emulsified with a homomixer. Thereafter, the emulsion was rapidly cooled while stirring to obtain an emulsion.
【0047】 〔処方例4〕 フォームマスク配合成分 配合量(重量%) (1)魚由来コラーゲン 0.00001 (2)緑藻抽出物 0.000001 (3)ステアリン酸 1.0 (4)ベヘニン酸 1.0 (5)自己乳化型モノステアリン酸グリセリン 1.5 (6)モノステアリン酸ポリオキシエチレン(5)グリセリン 2.5 (7)バチルアルコール 1.5 (8)香料 0.05 (9)グリセリン 5.0 (10)1, 3−ブチレングリコール 5.0 (11)ポリエチレングリコール1500 3.0 (12)メチルパラベン 0.1 (13)水酸化カリウム 0.15 (14)精製水 残 量 (15)液化石油ガス 6.0 (16)ジメチルエーテル 2.0 〈製法〉精製水に、魚由来コラーゲン、緑藻抽出物、グ
リセリン、1, 3−ブチレングリコール、ポリエチレン
グリコール1500、メチルパラベン、水酸化カリウム
を加え、70℃に加熱溶解した(水相)。次に、ステア
リン酸、ベヘニン酸、自己乳化型モノステアリン酸グリ
セリン、モノステアリン酸ポリオキシエチレン(5)、
グリセリン、バチルアルコール及び香料を加熱混合した
(油相)。前記水相に、この油相を添加して、均一に混
合したものを、容器に充填した。最後に、液化ガス、ジ
メチルエーテルを噴射剤として加え、フォームマスクを
得た。[Formulation Example 4] Blending amount of foam mask blending component (% by weight) (1) Fish-derived collagen 0.00001 (2) Green alga extract 0.000001 (3) Stearic acid 1.0 (4) Behenic acid 1 2.0 (5) Self-emulsifying glyceryl monostearate 1.5 (6) Polyoxyethylene monostearate (5) glycerin 2.5 (7) Bacyl alcohol 1.5 (8) Fragrance 0.05 (9) Glycerin 5.0 (10) 1,3-butylene glycol 5.0 (11) Polyethylene glycol 1500 3.0 (12) Methyl paraben 0.1 (13) Potassium hydroxide 0.15 (14) Remaining amount of purified water (15) Liquefied petroleum gas 6.0 (16) Dimethyl ether 2.0 <Preparation method> Purified water contains fish-derived collagen, green algae extract, glycerin, 1,3-butylene Glycol, polyethylene glycol 1500, methyl paraben, and potassium hydroxide were added and dissolved by heating at 70 ° C. (aqueous phase). Next, stearic acid, behenic acid, self-emulsifying glyceryl monostearate, polyoxyethylene monostearate (5),
Glycerin, batyl alcohol and fragrance were mixed by heating (oil phase). The oil phase was added to the aqueous phase, and the mixture was uniformly mixed and filled in a container. Finally, a liquefied gas and dimethyl ether were added as a propellant to obtain a foam mask.
【0048】 〔処方例5〕 軟膏配合成分 配合量(重量%) (1)動物由来コラーゲン 0.005 (2)紅藻抽出物 0.0025 (3)褐藻抽出物 0.0025 (4)パラジメチルアミノ安息香酸オクチル 4.0 (5)ブチルメトキシベンゾイルメタン 0.5 (6)酢酸トコフェロール 0.5 (7)パルミチン酸レチノール 1.0 (8)ステアリルアルコール 18.0 (9)モクロウ 20.0 (10)ポリオキシエチレン(10)モノオレイン酸エステル 0.25 (11)グリセリンモノステアリン酸エステル 0.3 (12)ワセリン 32.0 (13)精製水 残 量 〈製法〉精製水に、動物由来コラーゲン、紅藻抽出物、
褐藻抽出物を溶解し、70℃に保った(水相)。これと
は別に、その他の成分を、70℃で混合溶解した(油
相)。前記水相に、この油相を加え、ホモミキサーで均
一に乳化し、その後、冷却して、軟膏を得た。[Formulation Example 5] Ointment compounding ingredients (% by weight) (1) Animal-derived collagen 0.005 (2) Red algae extract 0.0025 (3) Brown algae extract 0.0025 (4) Paradimethyl Octyl aminobenzoate 4.0 (5) Butylmethoxybenzoylmethane 0.5 (6) Tocopherol acetate 0.5 (7) Retinol palmitate 1.0 (8) Stearyl alcohol 18.0 (9) Mokurou 20.0 ( 10) Polyoxyethylene (10) monooleate 0.25 (11) Glycerin monostearate 0.3 (12) Vaseline 32.0 (13) Purified water balance <Production method> Purified water and animal-derived collagen , Red algae extract,
The brown algae extract was dissolved and kept at 70 ° C. (aqueous phase). Separately, other components were mixed and dissolved at 70 ° C. (oil phase). The oil phase was added to the aqueous phase, and the mixture was uniformly emulsified with a homomixer and then cooled to obtain an ointment.
【0049】 〔処方例6〕 美容液配合成分 配合量(重量%) (1)魚由来コラーゲン 0.001 (2)緑藻抽出物 0.0001 (3)濃グリセリン 30.0 (4)1, 3−ブチレングリコール 20.0 (5)プロピレングリコール 20.0 (6)ポリエチレングリコール400 15.0 (7)ポリオキシエチレン(60)硬化ヒマシ油 5.0 (8)スクワラン 2.0 (9)流動パラフィン 3.0 (10)香料 0.1 (11)精製水 残 量 〈製法〉(1)〜(6)、(11)を混合した。これ
に、加熱溶解した(7)、(8)、(9)、(10)を
撹拌混合し、美容液を得た。[Formulation Example 6] Essence composition (% by weight) (1) Fish-derived collagen 0.001 (2) Green algae extract 0.0001 (3) Concentrated glycerin 30.0 (4) 1, 3 -Butylene glycol 20.0 (5) propylene glycol 20.0 (6) polyethylene glycol 400 15.0 (7) polyoxyethylene (60) hydrogenated castor oil 5.0 (8) squalane 2.0 (9) liquid paraffin 3.0 (10) Fragrance 0.1 (11) Remaining amount of purified water <Production method> (1) to (6) and (11) were mixed. Heat-dissolved (7), (8), (9), and (10) were stirred and mixed with this to obtain a serum.
【0050】 〔処方例7〕 クレンジングパック配合成分 配合量(重量%) (1)魚由来コラーゲン 0.01 (2)緑藻抽出物 0.1 (3)褐藻抽出物 0.05 (4)紅藻抽出物 0.05 (5)グリセリン 5.0 (6)1, 3−ブチレングリコール 3.0 (7)ジプロピレングリコール 2.0 (8)ブチルパラベン 0.05 (9)ベントナイト 5.0 (10)ベヘニルアルコール 1.0 (11)流動パラフィン 5.0 (12)モノステアリン酸ポリオキシエチレングリセリン 2.0 (13)カオリン 10.0 (14)酸化亜鉛 2.0 (15)精製水 残 量 〈製法〉(1)〜(9)、(15)を混合した。これ
に、加熱溶解した(10)〜(12)を撹拌混合後、さ
らに、(13)及び(14)を混合し、クレンジングパ
ックを得た。Formulation Example 7 Cleansing pack compounding ingredients (% by weight) (1) Fish-derived collagen 0.01 (2) Green algae extract 0.1 (3) Brown algae extract 0.05 (4) Red algae Extract 0.05 (5) Glycerin 5.0 (6) 1,3-butylene glycol 3.0 (7) Dipropylene glycol 2.0 (8) Butylparaben 0.05 (9) Bentonite 5.0 (10) ) Behenyl alcohol 1.0 (11) Liquid paraffin 5.0 (12) Polyoxyethylene glycerin monostearate 2.0 (13) Kaolin 10.0 (14) Zinc oxide 2.0 (15) Purified water balance <Production method > (1) to (9) and (15) were mixed. After heating and dissolving (10) to (12), the components (13) and (14) were further mixed to obtain a cleansing pack.
【0051】[0051]
【発明の効果】本発明により、肌荒れ予防・改善効果に
優れた皮膚外用剤が提供される。Industrial Applicability According to the present invention, there is provided a skin external preparation excellent in the effect of preventing and improving rough skin.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61P 17/00 A61K 31/00 617 17/16 617J A61K 35/80 35/80 Z 38/17 37/12 Fターム(参考) 4C083 AA082 AA111 AA112 AA122 AA161 AA162 AB032 AB212 AB442 AC012 AC022 AC072 AC102 AC122 AC172 AC212 AC242 AC302 AC342 AC352 AC402 AC422 AC432 AC442 AC482 AC582 AC662 AD042 AD431 AD432 AD512 AD622 AD662 CC02 CC04 CC05 CC07 CC23 DD08 DD22 DD23 DD31 EE12 FF05 4C084 AA01 AA02 AA18 AA19 CA07 CA45 MA02 MA63 NA14 ZA891 4C088 AA13 AA14 AA15 AC05 BA09 BA10 CA03 MA02 MA11 MA63 NA14 ZA89 ──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 7 Identification symbol FI theme coat ゛ (Reference) A61P 17/00 A61K 31/00 617 17/16 617J A61K 35/80 35/80 Z 38/17 37/12 F-term (reference) 4C083 AA082 AA111 AA112 AA122 AA161 AA162 AB032 AB212 AB442 AC012 AC022 AC072 AC102 AC122 AC172 AC212 AC242 AC302 AC342 AC352 AC402 AC422 AC432 AC442 AC482 AC582 AC662 AD042 AD431 AD432 AD512 AD622 AD662 CC02 CC04 DD05 CC07 DD23 DD 4C084 AA01 AA02 AA18 AA19 CA07 CA45 MA02 MA63 NA14 ZA891 4C088 AA13 AA14 AA15 AC05 BA09 BA10 CA03 MA02 MA11 MA63 NA14 ZA89
Claims (5)
る皮膚外用剤。1. An external preparation for skin containing collagen and seaweed extract as active ingredients.
求項1記載の皮膚外用剤。2. The external preparation for skin according to claim 1, wherein the collagen is marine collagen.
類に属する海藻及び褐藻類に属する海藻からなる群から
選ばれる1種又は2種以上の海藻の海藻抽出物である、
請求項1又は2記載の皮膚外用剤。3. The seaweed extract is a seaweed extract of one or more seaweeds selected from the group consisting of seaweeds belonging to red algae, seaweeds belonging to green algae and seaweeds belonging to brown algae.
An external preparation for skin according to claim 1 or 2.
に属する海藻がクロレラ及び褐藻類に属する海藻がマコ
ンブである、請求項3記載の皮膚外用剤。4. The external preparation for skin according to claim 3, wherein the seaweed belonging to the red algae is Numehanori and the seaweed belonging to the green algae is Chlorella and the seaweed belonging to the brown algae is Macomb.
の皮膚外用剤に、さらに海水乾燥物が配合されている皮
膚外用剤。5. An external preparation for skin, wherein the external preparation for skin according to any one of claims 1 to 4 is further mixed with a dried seawater.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11031325A JP2000229832A (en) | 1999-02-09 | 1999-02-09 | Skin lotion |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11031325A JP2000229832A (en) | 1999-02-09 | 1999-02-09 | Skin lotion |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2000229832A true JP2000229832A (en) | 2000-08-22 |
Family
ID=12328122
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP11031325A Withdrawn JP2000229832A (en) | 1999-02-09 | 1999-02-09 | Skin lotion |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2000229832A (en) |
Cited By (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003104837A (en) * | 2001-09-28 | 2003-04-09 | Mikimoto Pharmaceut Co Ltd | Emulsified composition |
| JP2003192528A (en) * | 2001-12-27 | 2003-07-09 | Nonogawa Shoji Kk | Cosmetic |
| JP2003192566A (en) * | 2001-12-27 | 2003-07-09 | Nonogawa Shoji Kk | Cosmetic |
| JP2003192565A (en) * | 2001-12-27 | 2003-07-09 | Nonogawa Shoji Kk | Cosmetic |
| JP2003201211A (en) * | 2001-12-28 | 2003-07-18 | Nonogawa Shoji Kk | Cosmetic |
| FR2837702A1 (en) * | 2002-03-26 | 2003-10-03 | Clarins Lab | COSMETIC COMPOSITION FOR SKIN CARE, PARTICULARLY AS NIGHT CARE |
| WO2003000222A3 (en) * | 2001-06-22 | 2004-04-29 | Gecomwert Anstalt | Cosmetic preparation with anti-wrinkle action |
| JP2006131543A (en) * | 2004-11-05 | 2006-05-25 | Pola Chem Ind Inc | Skin care preparation for external use containing oceanic skin benefit material |
| JP2006193463A (en) * | 2005-01-13 | 2006-07-27 | Pola Chem Ind Inc | Cosmetic |
| JP2008074784A (en) * | 2006-09-22 | 2008-04-03 | Mandom Corp | Skin care emulsified composition |
| JP2008195651A (en) * | 2007-02-13 | 2008-08-28 | Noevir Co Ltd | Humectant |
| JP2009084195A (en) * | 2007-09-28 | 2009-04-23 | Naris Cosmetics Co Ltd | Involucrin production promoter |
| JP2010528005A (en) * | 2007-05-22 | 2010-08-19 | アクセス ビジネス グループ インターナショナル リミテッド ライアビリティ カンパニー | Skin tightening and wrinkle removing composition and method of use |
| JP4870433B2 (en) * | 2003-11-28 | 2012-02-08 | タカラバイオ株式会社 | Ceramidase inhibitor |
| JP2013133324A (en) * | 2011-12-27 | 2013-07-08 | Dhc Co | Skin care preparation |
| WO2015082356A1 (en) * | 2013-12-03 | 2015-06-11 | Gerolymatos International S.A. | Ionic aqueous compositions |
| US9724292B2 (en) | 2012-06-18 | 2017-08-08 | The Procter & Gamble Company | Method of improving the appearance of aging skin |
| WO2020054972A1 (en) * | 2018-09-14 | 2020-03-19 | (주)더원코스메틱 | Skin whitening, anti-wrinkle and antioxidant functional cosmetic composition containing mixed extract of gloiopeltis tenax, palmaria palmata and himanthalia elongata as active ingredient, and preparation method therefor |
| CN111557955A (en) * | 2020-06-01 | 2020-08-21 | 成都丁因生物科技有限公司 | Compound for improving energy metabolism disorder of skin cells |
| KR102492105B1 (en) * | 2022-03-15 | 2023-01-30 | 애경산업(주) | Cosmetic composition |
| KR102492106B1 (en) * | 2022-03-15 | 2023-01-30 | 애경산업(주) | Cosmetic composition |
-
1999
- 1999-02-09 JP JP11031325A patent/JP2000229832A/en not_active Withdrawn
Cited By (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003000222A3 (en) * | 2001-06-22 | 2004-04-29 | Gecomwert Anstalt | Cosmetic preparation with anti-wrinkle action |
| JP2003104837A (en) * | 2001-09-28 | 2003-04-09 | Mikimoto Pharmaceut Co Ltd | Emulsified composition |
| JP2003192565A (en) * | 2001-12-27 | 2003-07-09 | Nonogawa Shoji Kk | Cosmetic |
| JP2003192566A (en) * | 2001-12-27 | 2003-07-09 | Nonogawa Shoji Kk | Cosmetic |
| JP2003192528A (en) * | 2001-12-27 | 2003-07-09 | Nonogawa Shoji Kk | Cosmetic |
| JP2003201211A (en) * | 2001-12-28 | 2003-07-18 | Nonogawa Shoji Kk | Cosmetic |
| FR2837702A1 (en) * | 2002-03-26 | 2003-10-03 | Clarins Lab | COSMETIC COMPOSITION FOR SKIN CARE, PARTICULARLY AS NIGHT CARE |
| JP4870433B2 (en) * | 2003-11-28 | 2012-02-08 | タカラバイオ株式会社 | Ceramidase inhibitor |
| JP2012036213A (en) * | 2003-11-28 | 2012-02-23 | Takara Bio Inc | Method for producing ceramidase inhibitor |
| JP2006131543A (en) * | 2004-11-05 | 2006-05-25 | Pola Chem Ind Inc | Skin care preparation for external use containing oceanic skin benefit material |
| JP2006193463A (en) * | 2005-01-13 | 2006-07-27 | Pola Chem Ind Inc | Cosmetic |
| JP2008074784A (en) * | 2006-09-22 | 2008-04-03 | Mandom Corp | Skin care emulsified composition |
| JP2008195651A (en) * | 2007-02-13 | 2008-08-28 | Noevir Co Ltd | Humectant |
| JP2010528005A (en) * | 2007-05-22 | 2010-08-19 | アクセス ビジネス グループ インターナショナル リミテッド ライアビリティ カンパニー | Skin tightening and wrinkle removing composition and method of use |
| JP2009084195A (en) * | 2007-09-28 | 2009-04-23 | Naris Cosmetics Co Ltd | Involucrin production promoter |
| JP2013133324A (en) * | 2011-12-27 | 2013-07-08 | Dhc Co | Skin care preparation |
| US9801811B1 (en) | 2012-06-18 | 2017-10-31 | The Procter & Gamble Company | Compositions for improving the appearance of aging skin |
| US9724292B2 (en) | 2012-06-18 | 2017-08-08 | The Procter & Gamble Company | Method of improving the appearance of aging skin |
| US10485819B2 (en) | 2013-12-03 | 2019-11-26 | Gerolymatos International S.A. | Ionic aqueous polysaccharide compositions |
| EA031541B1 (en) * | 2013-12-03 | 2019-01-31 | Геролиматос Интернэшнл С.А. | Ionic aqueous compositions |
| WO2015082356A1 (en) * | 2013-12-03 | 2015-06-11 | Gerolymatos International S.A. | Ionic aqueous compositions |
| AU2014359488B2 (en) * | 2013-12-03 | 2020-01-23 | Gerolymatos International S.A. | Ionic aqueous compositions |
| US11672821B2 (en) | 2013-12-03 | 2023-06-13 | Gerolymatos International S.A. | Methods for treating respiratory conditions using ionic aqueous polysaccharide compositions |
| WO2020054972A1 (en) * | 2018-09-14 | 2020-03-19 | (주)더원코스메틱 | Skin whitening, anti-wrinkle and antioxidant functional cosmetic composition containing mixed extract of gloiopeltis tenax, palmaria palmata and himanthalia elongata as active ingredient, and preparation method therefor |
| CN111557955A (en) * | 2020-06-01 | 2020-08-21 | 成都丁因生物科技有限公司 | Compound for improving energy metabolism disorder of skin cells |
| KR102492105B1 (en) * | 2022-03-15 | 2023-01-30 | 애경산업(주) | Cosmetic composition |
| KR102492106B1 (en) * | 2022-03-15 | 2023-01-30 | 애경산업(주) | Cosmetic composition |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2000229832A (en) | Skin lotion | |
| JP3696271B2 (en) | Whitening cosmetics | |
| WO2002007745A1 (en) | Antipruritic compositions and compositions promoting wound healing | |
| JP3665360B2 (en) | Active oxygen scavenger and composition containing the same | |
| JP2001206835A (en) | Collagen synthesis promoter and collagen metabolism activator | |
| KR20180118409A (en) | Nutrition Cream Containing Ergothioneine and Its Manufacturing Method | |
| JP2003277223A (en) | Matrix metalloprotease activity inhibitor and skin elasticity maintaining cosmetic. | |
| JP2003055190A (en) | Collagenase inhibitor and anti-aging cosmetic | |
| JP2000016917A (en) | Skin whitening cosmetic | |
| JP3263409B2 (en) | External preparation for skin | |
| JP2001072571A (en) | Skin preparation for external use | |
| JP3441387B2 (en) | Moisturizer, skin cosmetics and bath additives | |
| JP3712673B2 (en) | Gel composition and oil-in-water (O / W) type composition | |
| TW202308591A (en) | Cosmetic | |
| JP3643788B2 (en) | Topical skin preparation | |
| JP2010077041A (en) | Bleaching ingredient and skin cosmetic | |
| JP5313524B2 (en) | Anti-inflammatory agent and anti-inflammatory skin external preparation | |
| JP2001031554A (en) | External preparation for skin | |
| JP2004035431A (en) | Skin care preparation for externa use | |
| JP4653513B2 (en) | Skin preparation | |
| JP2003171226A (en) | Skin care preparation | |
| JP2015107953A (en) | Composition for toiletry products containing plant extract | |
| JP2003034644A (en) | Hyalonidase inhibitor and composition for external use on skin | |
| JP7276887B2 (en) | Type III collagen production promoter and anti-aging cosmetic | |
| JP2811479B2 (en) | Hair restoration |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A300 | Withdrawal of application because of no request for examination |
Free format text: JAPANESE INTERMEDIATE CODE: A300 Effective date: 20060509 |